middle.news
Ceretas takes Alzheimer’s ultrasound program into Phase 2 recruitment
9:23am on Friday 30th of October, 2026 AEDT
•
Medical Technology
Read Story
Ceretas takes Alzheimer’s ultrasound program into Phase 2 recruitment
9:23am on Friday 30th of October, 2026 AEDT
Key Points
First CERE-CALM patient enrolled shortly after quarter end
$7.1 million cash balance and 5.4 quarters of funding at reported burn rate
Phase 2 trial targeting at least 60 participants across three Australian sites
Final $692,578 CUREator+ tranche received after functional device prototypes were accepted
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ceretas (ASX:CTS)
OPEN ARTICLE